Skip to content
S

Satyanarayana S. V. Padi

Publications (8)

Nuclear PPAR-γ Activation Modulates Inflammation and Oxidative Stress in Attenuating Chemotherapy-Induced Neuropathic Pain in Vivo

Haritha Pasupulati, Satyanarayana S. V. Padi, Sujatha Dodoala & Prasad V. S. R. G. Koganti · Journal of Pharmaceutical Research International · 2021

Background: Paclitaxel-induced painful neuropathy is a major dose-limiting side effect and can persist for up to two years after completing treatment that greatly affects both the course of chemotherapy and quality of life in cancer patients. Peroxisome proliferator-activated rec...

Open access Research Article 10.9734/jpri/2021/v33i38B32112

Pharmacotherapy for Diabetes in Chronic Kidney Disease: A Basic Overview

Akhila Gundeti, Haritha Pasupulati & Satyanarayana S. V. Padi · Asian Journal of Research in Nephrology · 2026

Diabetes mellitus (DM) is one of the most common causes and comorbidities in chronic kidney disease (CKD) globally. Particularly, DM in CKD patients increases the overall risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. Rece...

Open access Research Article 10.9734/ajrn/2026/v9i1125

Pharmacotherapy for Hypertension in Chronic Kidney Disease: An Overview

Akhila Gundeti, Haritha Pasupulati & Satyanarayana S. V. Padi · International Journal of Advances in Nephrology Research · 2026

Chronic kidney disease (CKD) is one of the leading causes of death. It is characterized by progressive decline in glomerular filtration rate (GFR), irreversible structural and functional kidney damage often associated with co-morbidities and multiple complications, including hype...

Open access Research Article 10.9734/ijanr/2026/v9i197

Drug Repurposing for COVID-19: Current Status of Potential Therapeutics

Pravalika Avirineni, Sudheer K. Dundigalla & Satyanarayana S. V. Padi · Journal of Advances in Medical and Pharmaceutical Sciences · 2023

The maneuver clinical investigation of an effective drug for coronavirus disease 2019 (COVID-19) is still ongoing and the milieu of a successful investigational drug with proven efficacy is still obscure. Drug repurposing is a method to identify new therapeutic uses for existing...

Open access Research Article 10.9734/jamps/2023/v25i11653

Emergence of Third Generation Tetracyclines: New Magic Bullets to Tackle Antibiotic Resistance in the Post-antibiotic Era

Pranitha Jetty, Soni Gaddam & Satyanarayana S. V. Padi · Asian Journal of Research in Infectious Diseases · 2023

Tetracyclines are broad-spectrum antibiotics effective against a wide variety of microorganisms including bacteria, both Gram-positive and Gram-negative, mycoplasmas, rickettsiae, chlamydiae, and protozoan parasites. Owing to their broad-spectrum antimicrobial activities and inex...

Open access Research Article 10.9734/ajrid/2023/v13i4271

Hospital Antibiotic Prescribing Pattern in General Surgery Specialty: Analysis Based on the WHO Access, Watch and Reserve (AWaRe) Classification

Mounika Peddireddy, Juveriya Mahin, Amarnath Uppu & Satyanarayana S. V. Padi · Journal of Pharmaceutical Research International · 2021

Background: Surgical site infections are a prevalent cause of nosocomial infections that require antibiotic prophylaxis. Emergence and spread of antimicrobial resistance is a major global public health issue that must be addressed. Eventually, antibiotic prescribing pattern shoul...

Open access Research Article 10.9734/jpri/2021/v33i41B32339

Pre-emptive PPAR-γ Activation Abolishes Development of Nerve Injury-induced Behavioral Hypersensitivity: Elucidating Underlying Mechanisms

Seema Thakur, Haritha Pasupulati, Saurabh Sharma & Satyanarayana S. V. Padi · Journal of Pharmaceutical Research International · 2021

Background: Neuropathic pain is a chronic incapacitating painful condition for which there is no effective treatment. The peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear transcription factors that play key roles in modulating immune and inflammato...

Open access Research Article 10.9734/jpri/2021/v33i39B32176

Antibiotic Prescribing Practices in Primary Care Settings Using 2019 WHO AWaRe Framework

Haritha Pasupulati, Vishal Avadhanula, Amit Mamilla, Mahadev Bamini & Satyanarayana S. V. Padi · Journal of Pharmaceutical Research International · 2021

Background: Bacteria have ability to rapidly evolve, develop strategies to resist antibiotics, and reduce the effectiveness of antibiotics. The emergence and spread of antimicrobial resistance is an important global public health challenge to tackle. Studying antibiotic prescribi...

Open access Research Article 10.9734/jpri/2021/v33i37A31980